Day: May 11, 2020

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — Medley Capital Corporation (NYSE: MCC) (TASE: MCC) (the “Company”) today announced financial results for the quarter ended March 31, 2020.Second Quarter SummaryNet asset value (“NAV”) of $2.60 per shareNet investment loss of $(0.08) per shareThe board of directors did not declare a dividend this quarterPortfolio InvestmentsThe total value of our investments was $255.9 million at March 31, 2020. During the quarter ended March 31, 2020, the Company originated $6.6 million of investments and had $20.4 million of repayments and sales, resulting in net repayments and sales of $13.8 million. As of March 31, 2020, the Company had investments in securities of 44 portfolio companies with approximately 41.4% consisting of senior secured first lien investments, 9.9% consisting of senior secured second...

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — Consolidated Edison, Inc. (Con Edison) (NYSE: ED) will hold its annual meeting of stockholders (the “Annual Meeting”) in a virtual-only meeting format on Monday, May 18, 2020, at 10:00 a.m. Eastern Daylight Time (“EDT”).As part of Con Edison’s effort to maintain a safe and healthy environment at its Annual Meeting and to protect the well-being of its employees and stockholders, after taking into account the guidance and protocols issued by public health authorities and federal, state and local governments regarding the novel coronavirus disease, COVID-19, Con Edison has decided to host its Annual Meeting by means of a virtual-only format this year at www.meetingcenter.io/249286494.  Con Edison has designed the virtual Annual Meeting to offer the same participation opportunities as an in-person...

MCLA-128, zenocutuzumab, Phase 1/2 eNRGy trial remains on trackMCLA-117 program update to be presented at upcoming medical meetingAnand Mehra, M.D. to succeed Russell Greig, Ph.D. as Chairman and Paolo Pucci Nominated for Appointment to Merus Board of DirectorsUTRECHT, The Netherlands and CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and TriclonicsTM), today announced financial results for the first quarter that ended March 31, 2020, and provided a business update.“We have made progress on our clinical programs despite the effects of the current COVID-19 pandemic, and remain on track to provide a clinical update on zenocutuzumab (Zeno) for NRG1 fusion cancers...

Reports first-quarter revenues of $64 million; net loss of $1 million; GAAP EPS loss of $0.03; adjusted EPS of $0.02; adjusted EBITDA of $4 millionDelivers strong first-quarter cash flow from operating activities of approximately $5 million; reports quarter-end cash balance of more than $17 millionReduces cost base in response to economic conditionsSees increased demand for cost optimization, supplier/risk management, digital workplace and asset monetization servicesSets second-quarter 2020 guidance: revenues of between $53 million and $55 million and adjusted EBITDA of between $6 million and $7 millionSTAMFORD, Conn., May 11, 2020 (GLOBE NEWSWIRE) — Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, today announced financial results for the first quarter ended March 31, 2020.“We...

BATON ROUGE, La., May 11, 2020 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the UBS Global Healthcare Conference 2020 on Monday, May 18, 2020.The presentation will begin at 3:00 p.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.About Amedisys:Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to...

Columbus, OH, May 11, 2020 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020, at 12:30 p.m Eastern Time.  To hear a live webcast of the presentation, visit the investor relations page on the Company’s Web site at www.mt.com/investors.  A replay of the webcast will be available for seven days.METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including...

WESTLAKE, Texas, May 11, 2020 (GLOBE NEWSWIRE) — Core-Mark Holding Company, Inc. (NASDAQ: CORE), one of the largest marketers of food, fresh and broad-line supply solutions to the convenience retail industry in North America, announced today that it will webcast its presentation from the 2020 BMO Farm to Market Conference on Wednesday May 13, 2020 beginning at 2:00 p.m. Eastern.The live webcast can be accessed at www.core-mark.com.  An archived replay of the presentation will be available shortly after the live event is completed and will remain on Core-Mark’s website for 30 days.Core-MarkCore-Mark is one of the largest marketers of food, fresh and broad-line supply solutions to the convenience retail industry in North America. Founded in 1888, Core-Mark offers a full range of products, marketing programs and technology solutions...

CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative cell therapies for solid tumors, today announced financial results for the first quarter ended March 31, 2020, and provided corporate updates.Recent Program and Corporate HighlightsAnnounced plans to prioritize resources towards advancing its preclinical program, BOXR1030, for the treatment of solid tumor cancers: On March 2nd, Unum announced a corporate restructuring plan to prioritize resources towards advancing its preclinical program, BOXR1030, for the treatment of solid tumor cancers. Unum’s BOXR1030 expresses a glypican-3 (GPC3) targeted CAR and incorporates the novel transgene glutamic-oxaloacetic transaminase 2 (GOT2) to improve T cell function in the solid tumor microenvironment...

First quarter 2020 product revenue increased 95% year-over-year to $11.9 millionNDA for IV tramadol accepted for review by FDA; assigned PDUFA date of October 10, 2020Agreement executed with Columbia University to develop a broad platform technology to effectively deliver novel, proprietary oligonucleotides to bind and directly disable mutant DNA with an initial target of KRAS-driven cancers; platform is also being explored as a potential treatment for coronavirusesNEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company, today announced financial results and recent corporate highlights for the first quarter ended March 31, 2020.Lindsay A. Rosenwald, M.D., Fortress’ Chairman, President and Chief Executive Officer, said, “The first quarter of 2020 was another...

New York, NY, May 11, 2020 (GLOBE NEWSWIRE) — AMCI Acquisition Corp. (the “Company”) is pleased to announce that it has entered into a non-binding letter of intent (the “Letter of Intent”) with an established mining company (the “Third Party”) for an initial business combination. Under the terms of the Letter of Intent, the Company would acquire an attractive portfolio of copper production interests (the “Portfolio”). The Portfolio is underpinned by a long-standing, producing operation located in one of the world’s most productive copper belts, which is forecasted to produce in excess of 50,000 metric tons of copper in 2021. The new copper production focused business will be led by an experienced management team with a world-class development and operating track record. The Company will seek to utilize its initial asset base and financial...